✦ LIBER ✦

Polymer-supported radiopharmaceuticals: [131I]MIBG and [123I]MIBG

✍ Scribed by Duncan H. Hunter; Xizhen Zhu

Publisher: John Wiley and Sons
Year: 1999
Tongue: French
Weight: 399 KB
Volume: 42
Category: Article
ISSN: 0022-2135
DOI: 10.1002/(sici)1099-1344(199907)42:7<653::aid-jlcr227>3.0.co;2-q

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Radiochemistry, biochemistry, and kineti

Radiochemistry, biochemistry, and kinetics of131I-metaiodobenzylguanidine (MIBG) and123I-MIBG: Clinical implications of the use of123I-MIBG

✍ Shapiro, B. ;Gross, M. D. 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 792 KB

Metaiodobenzylguanidine (MIBG) is actively concentrated in adrenergic neuroendocrine tissues and tumors by an active, energy- and sodium-dependent, high-affinity, saturable mechanism. This has proved successful, when labeled with 131-I or 123-I, in scintigraphically depicting pheochromocytomas and n

131I MIBG therapy in neuroblastoma: Mech

131I MIBG therapy in neuroblastoma: Mechanisms, rationale, and current status

✍ Tepmongkol, Supatporn; Heyman, Sydney 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB 👁 1 views

I MIBG has been used as palliative treatment of neuroblastoma patients with recurrent or persistent disease who failed other modalities of treatment. Since the results were promising, the concept arose of using it in conjunction with other modalities, either as an up-front treatment or as combinatio

Treatment of neuroblastoma with131I-MIBG

Treatment of neuroblastoma with131I-MIBG: Dosimetric problems and perspectives

✍ Beierwaltes, William H. 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 402 KB

Between 7/3/80 and 5/7/86 we gave 32 of our neuroblastoma patients 62 diagnostic doses of metaiodobenzylguanidine (MIBG) and 12 patients 20 treatment doses. Our conclusion from our diagnostic dose studies is that MIBG should be used for staging the extent of neuroblastoma before therapy is started,

Combined111In-pentetreotide scintigraphy

Combined111In-pentetreotide scintigraphy and123I-mIBG scintigraphy in neuroblastoma provides prognostic information

✍ Schilling, Freimut H. ;Bihl, Heiner ;Jacobsson, Hans ;Ambros, Peter F. ;Martinss 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB

Cardiac 123I-MIBG scintigraphy in patien

Cardiac 123I-MIBG scintigraphy in patients with essential tremor

✍ Phil Hyu Lee; Ji Won Kim; Oh Young Bang; In Soo Joo; Seok-Nam Yoon; Kyoon Huh 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB

In some cases, it is difficult to differentiate essential tremor (ET) from Parkinson's disease (PD), especially in the early stages of the disease. We investigated cardiac sympathetic dysfunction using (123)I-metaiodobenzylguanidine (MIBG) myocardial scintigraphy in 22 patients with ET, in compariso

123I-MIBG cardiac scintigraphy in Lewy b

123I-MIBG cardiac scintigraphy in Lewy body–related disorders

✍ Giorgio Treglia; Antonio Bagnato; Daniela Di Giuda; Alessandro Giordano 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB

Although we are sympathetic to Reynolds and Slocum's concerns, 1 their editorial errs on several points. The authors cite deference to regulatory (presumably Food and Drug Administration) approval as a constraint. The FDA has long recognized broad physician discretion in using FDAapproved drugs or d